Skip to main content
. 2015 Aug 25;10(8):e0134193. doi: 10.1371/journal.pone.0134193

Fig 2. Percentage reduction in levels of coagulation biomarkers and TCD velocities in Standard Care vs. Transfusion subjects, comparing study exit to baseline values.

Fig 2

von Willibrand Factor (VWF) (A), thrombin antithrombin (TAT) complex (B), D-dimer (C) and TCD velocity (D). SC and Tx represents sickle cell subjects randomized to the Standard Care and Transfusion arms respectively. *** = p <0.001 and **** = p <0.0001.